Skip to main content
Top
Published in: BMC Infectious Diseases 1/2024

Open Access 01-12-2024 | Influenza | Research

Uncovering the burden of Influenza in children in Portugal, 2008–2018

Authors: Alberto Caldas Afonso, Catarina Gouveia, Gustavo Januário, Mafalda Carmo, Hugo Lopes, Hélène Bricout, Catarina Gomes, Filipe Froes

Published in: BMC Infectious Diseases | Issue 1/2024

Login to get access

Abstract

Background

Despite their higher risk of developing severe disease, little is known about the burden of influenza in Portugal in children aged < 5 years old. This study aims to cover this gap by estimating the clinical and economic burden of severe influenza in children, in Portugal, during ten consecutive influenza seasons (2008/09-2017/18).

Methods

We reviewed hospitalizations in children aged < 5 years old using anonymized administrative data covering all public hospitals discharges in mainland Portugal. The burden of hospitalization and in-hospital mortality directly coded as due to influenza was supplemented by the indirect burden calculated from excess hospitalization and mortality (influenza-associated), estimated for four groups of diagnoses (pneumonia or influenza, respiratory, respiratory or cardiovascular, and all-cause), through cyclic regression models integrating the incidence of influenza. Means were reported excluding the H1N1pdm09 pandemic (2009/10).

Results

The mean annual number of hospitalizations coded as due to influenza was 189 (41.3 cases per 100,000 children aged < 5 years old). Hospitalization rates decreased with increasing age. Nine-in-ten children were previously healthy, but the presence of comorbidities increased with age. Children stayed, on average, 6.1 days at the hospital. Invasive mechanical ventilation was used in 2.4% of hospitalizations and non-invasive in 3.1%. Influenza-associated excess hospitalizations between 2008 and 2018 were estimated at 1,850 in pneumonia or influenza, 1,760 in respiratory, 1,787 in respiratory or cardiovascular, and 1,879 in all-cause models. A total of 95 influenza-associated excess deaths were estimated in all-cause, 14 in respiratory or cardiovascular, and 9 in respiratory models. Over ten years, influenza hospitalizations were estimated to have cost the National Health Service at least €2.9 million, of which 66.5% from healthy children.

Conclusions

Influenza viruses led to a high number of hospitalizations in children. Most were previously healthy. Results should lead to a reflection on the adequate preventive measures to protect this age group.
Appendix
Available only for authorised users
Footnotes
1
Mean for nine seasons (2008/2009 to 2017/2018), i.e., excluding the H1N1pdm09 pandemic (2009/10).
 
Literature
1.
go back to reference Organization WH. Vaccines against influenza WHO position paper—November 2012. In: Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire vol. 87; 2012: 461–476. Organization WH. Vaccines against influenza WHO position paper—November 2012. In: Weekly Epidemiological Record = Relevé épidémiologique hebdomadaire vol. 87; 2012: 461–476.
2.
go back to reference Zambon M. Influenza surveillance and laboratory diagnosis. Textbook of Influenza 2013:229–49. Zambon M. Influenza surveillance and laboratory diagnosis. Textbook of Influenza 2013:229–49.
3.
go back to reference Nayak J, Hoy G, Gordon A. Influenza in children. Cold Spring Harbor Perspectives in Medicine 2021, 11(1). Nayak J, Hoy G, Gordon A. Influenza in children. Cold Spring Harbor Perspectives in Medicine 2021, 11(1).
4.
go back to reference Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of Influenza Illness in children with Asthma and other chronic medical conditions. Pediatrics. 2000;137(6):856–64. Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of Influenza Illness in children with Asthma and other chronic medical conditions. Pediatrics. 2000;137(6):856–64.
5.
go back to reference Grohskopf LA. Prevention and Control of Seasonal Influenza with vaccines: recommendations of the Advisory Committee on Immunization practices—United States, 2022–23 Influenza season. MMWR Recommendations and Reports 2022, 71. Grohskopf LA. Prevention and Control of Seasonal Influenza with vaccines: recommendations of the Advisory Committee on Immunization practices—United States, 2022–23 Influenza season. MMWR Recommendations and Reports 2022, 71.
6.
go back to reference Organization WH. Seasonal influenza vaccines: an overview for decision-makers. 2020. Organization WH. Seasonal influenza vaccines: an overview for decision-makers. 2020.
8.
go back to reference Saúde D-G. Campanha de Vacinação Sazonal contra a Gripe: OutonoInverno 2022–2023. In., vol. 007/2022; 2022. Saúde D-G. Campanha de Vacinação Sazonal contra a Gripe: OutonoInverno 2022–2023. In., vol. 007/2022; 2022.
9.
go back to reference Tillard C, Chazard E, Faure K, Bartolo S, Martinot A, Dubos F. Burden of Influenza Disease in children under 2 years of age hospitalized between 2011 and 2020 in France. J Infect. 2022;84(2):145–50.PubMedCrossRef Tillard C, Chazard E, Faure K, Bartolo S, Martinot A, Dubos F. Burden of Influenza Disease in children under 2 years of age hospitalized between 2011 and 2020 in France. J Infect. 2022;84(2):145–50.PubMedCrossRef
10.
go back to reference Froes F, Carmo M, Lopes H, Bizouard G, Gomes C, Martins M, Bricout H, de Courville C, de Sousa JC, Rabaçal C, et al. Excess hospitalizations and mortality associated with seasonal Influenza in Portugal, 2008–2018. BMC Infect Dis. 2022;22(1):726.PubMedPubMedCentralCrossRef Froes F, Carmo M, Lopes H, Bizouard G, Gomes C, Martins M, Bricout H, de Courville C, de Sousa JC, Rabaçal C, et al. Excess hospitalizations and mortality associated with seasonal Influenza in Portugal, 2008–2018. BMC Infect Dis. 2022;22(1):726.PubMedPubMedCentralCrossRef
11.
go back to reference Pumarola T, Díez-Domingo J, Martinón-Torres F, Redondo Margüello E, de Lejarazu Leonardo RO, Carmo M, Bizouard G, Drago G, López-Belmonte J, Bricout H. Excess hospitalizations and mortality associated with seasonal Influenza in Spain, 2008–2018. BMC Infect Dis. 2023;23(1):86.PubMedPubMedCentralCrossRef Pumarola T, Díez-Domingo J, Martinón-Torres F, Redondo Margüello E, de Lejarazu Leonardo RO, Carmo M, Bizouard G, Drago G, López-Belmonte J, Bricout H. Excess hospitalizations and mortality associated with seasonal Influenza in Spain, 2008–2018. BMC Infect Dis. 2023;23(1):86.PubMedPubMedCentralCrossRef
12.
go back to reference Gil-de-Miguel Á, Martinón-Torres F, Díez-Domingo J, de Lejarazu Leonardo RO, Pumarola T, Carmo M, Drago G, López-Belmonte JL, Bricout H, de Courville C. Clinical and economic burden of physician-diagnosed Influenza in adults during the 2017/2018 epidemic season in Spain. BMC Public Health. 2022;22(1):2369.PubMedPubMedCentralCrossRef Gil-de-Miguel Á, Martinón-Torres F, Díez-Domingo J, de Lejarazu Leonardo RO, Pumarola T, Carmo M, Drago G, López-Belmonte JL, Bricout H, de Courville C. Clinical and economic burden of physician-diagnosed Influenza in adults during the 2017/2018 epidemic season in Spain. BMC Public Health. 2022;22(1):2369.PubMedPubMedCentralCrossRef
13.
go back to reference Martinón-Torres F, Carmo M, Platero L, Drago G, López-Belmonte JL, Bangert M, Díez-Domingo J, Garcés-Sánchez M. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study. BMC Infect Dis. 2022;22(1):759.PubMedPubMedCentralCrossRef Martinón-Torres F, Carmo M, Platero L, Drago G, López-Belmonte JL, Bangert M, Díez-Domingo J, Garcés-Sánchez M. Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study. BMC Infect Dis. 2022;22(1):759.PubMedPubMedCentralCrossRef
14.
go back to reference Bandeira T, Carmo M, Lopes H, Gomes C, Martins M, Guzman C, Bangert M, Rodrigues F, Januário G, Tomé T. Burden and severity of children’s hospitalizations by respiratory syncytial virus in Portugal, 2015–2018. Influenza Other Respir Viruses. 2023;17(1):e13066.PubMedCrossRef Bandeira T, Carmo M, Lopes H, Gomes C, Martins M, Guzman C, Bangert M, Rodrigues F, Januário G, Tomé T. Burden and severity of children’s hospitalizations by respiratory syncytial virus in Portugal, 2015–2018. Influenza Other Respir Viruses. 2023;17(1):e13066.PubMedCrossRef
15.
go back to reference Gil-de-Miguel Á, Díez-Domingo J, Martinón-Torres F, Margüello ER, de Lejarazu Leonardo RO, Pumarola T, de Sousa JC, Rabaçal C, Raposo J, Cordeiro CR. Addressing Influenza’s underestimated burden–Iberian experts call to action. BMC Infect Dis. 2023;23(1):308.PubMedPubMedCentralCrossRef Gil-de-Miguel Á, Díez-Domingo J, Martinón-Torres F, Margüello ER, de Lejarazu Leonardo RO, Pumarola T, de Sousa JC, Rabaçal C, Raposo J, Cordeiro CR. Addressing Influenza’s underestimated burden–Iberian experts call to action. BMC Infect Dis. 2023;23(1):308.PubMedPubMedCentralCrossRef
16.
go back to reference Instituto Nacional de Estatística: Óbitos gerais, diários, por causa de morte. In.: INE. Received in. July 2020; 2020. Instituto Nacional de Estatística: Óbitos gerais, diários, por causa de morte. In.: INE. Received in. July 2020; 2020.
17.
go back to reference Instituto Nacional de Saúde Doutor Ricardo Jorge. : Taxa de incidência de síndrome gripal semanal. In.: INSA. Received in July 2020.; 2020. Instituto Nacional de Saúde Doutor Ricardo Jorge. : Taxa de incidência de síndrome gripal semanal. In.: INSA. Received in July 2020.; 2020.
18.
go back to reference Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 Influenza pandemic in France: comparison to seasonal Influenza and the A/H3N2 pandemic. PLoS ONE. 2012;7(9):e45051–1.PubMedPubMedCentralCrossRef Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 Influenza pandemic in France: comparison to seasonal Influenza and the A/H3N2 pandemic. PLoS ONE. 2012;7(9):e45051–1.PubMedPubMedCentralCrossRef
19.
go back to reference Hamilton MA, Calzavara A, Emerson SD, Djebli M, Sundaram ME, Chan AK, Kustra R, Baral SD, Mishra S, Kwong JC. Validating International classification of Disease 10th revision algorithms for identifying Influenza and respiratory syncytial virus hospitalizations. PLoS ONE. 2021;16(1):e0244746.PubMedPubMedCentralCrossRef Hamilton MA, Calzavara A, Emerson SD, Djebli M, Sundaram ME, Chan AK, Kustra R, Baral SD, Mishra S, Kwong JC. Validating International classification of Disease 10th revision algorithms for identifying Influenza and respiratory syncytial virus hospitalizations. PLoS ONE. 2021;16(1):e0244746.PubMedPubMedCentralCrossRef
20.
go back to reference Mendes-da-Silva A, Gonçalves-Pinho M, Freitas A, Azevedo I. Trends in hospitalization for acute bronchiolitis in Portugal: 2000–2015. Pulmonology. 2019;25(3):154–61.PubMedCrossRef Mendes-da-Silva A, Gonçalves-Pinho M, Freitas A, Azevedo I. Trends in hospitalization for acute bronchiolitis in Portugal: 2000–2015. Pulmonology. 2019;25(3):154–61.PubMedCrossRef
21.
go back to reference Instituto Nacional de Estatística: População residente em Portugal. In.: INE. Retrieved in. July 2020; 2020. Instituto Nacional de Estatística: População residente em Portugal. In.: INE. Retrieved in. July 2020; 2020.
22.
go back to reference Wang X, Li Y, O’Brien KL, Madhi SA, Widdowson MA, Byass P, Omer SB, Abbas Q, Ali A, Amu A, et al. Global burden of Respiratory Infections associated with seasonal Influenza in children under 5 years in 2018: a systematic review and modelling study. The Lancet Global Health. 2020;8(4):e497–e510.PubMedPubMedCentralCrossRef Wang X, Li Y, O’Brien KL, Madhi SA, Widdowson MA, Byass P, Omer SB, Abbas Q, Ali A, Amu A, et al. Global burden of Respiratory Infections associated with seasonal Influenza in children under 5 years in 2018: a systematic review and modelling study. The Lancet Global Health. 2020;8(4):e497–e510.PubMedPubMedCentralCrossRef
23.
go back to reference Hospitalization of Children Aged <5 Years Due to Influenza: Study Based on the National Hospitalization Registry. Children (Basel, Switzerland) 2022, 9(7). Hospitalization of Children Aged <5 Years Due to Influenza: Study Based on the National Hospitalization Registry. Children (Basel, Switzerland) 2022, 9(7).
24.
go back to reference Cromer D, Van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of Influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014;68(4):363–71.PubMedCrossRef Cromer D, Van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of Influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014;68(4):363–71.PubMedCrossRef
25.
go back to reference Hauge SH, Bakken IJ, De Blasio BF, Håberg SE. Risk conditions in children hospitalized with Influenza in Norway, 2017–2019. BMC Infect Dis. 2020;20(1):1–9.CrossRef Hauge SH, Bakken IJ, De Blasio BF, Håberg SE. Risk conditions in children hospitalized with Influenza in Norway, 2017–2019. BMC Infect Dis. 2020;20(1):1–9.CrossRef
26.
go back to reference Rodrigues E, Machado A, Silva S, Nunes B. Excess Pneumonia and Influenza hospitalizations associated with Influenza epidemics in Portugal from season 1998/1999 to 2014/2015. Influenza Other Respir Viruses. 2018;12(1):153–60.PubMedPubMedCentralCrossRef Rodrigues E, Machado A, Silva S, Nunes B. Excess Pneumonia and Influenza hospitalizations associated with Influenza epidemics in Portugal from season 1998/1999 to 2014/2015. Influenza Other Respir Viruses. 2018;12(1):153–60.PubMedPubMedCentralCrossRef
27.
go back to reference Schmidt SS, Iuliano AD, Vestergaard LS, Mazagatos-Ateca C, Larrauri A, Brauner JM, Olsen SJ, Nielsen J, Salomon JA, Krause TG. All‐cause versus cause‐specific excess deaths for estimating Influenza‐associated mortality in Denmark, Spain, and the United States. Influenza and other respiratory viruses 2022. Schmidt SS, Iuliano AD, Vestergaard LS, Mazagatos-Ateca C, Larrauri A, Brauner JM, Olsen SJ, Nielsen J, Salomon JA, Krause TG. All‐cause versus cause‐specific excess deaths for estimating Influenza‐associated mortality in Denmark, Spain, and the United States. Influenza and other respiratory viruses 2022.
28.
go back to reference Rodrigues AP, Silva S, Torres AR, Guiomar R, Pechirra P, Cristóvão P, Baltazar N. Mortalidade atribuível Ao vírus sincicial respiratório em Portugal entre 2014 e 2018. Instituto Nac De Saúde Doutor Ricardo Jorge Observações Bol Epidemiológico 2019, Número 25(Artigos breves nº2). Rodrigues AP, Silva S, Torres AR, Guiomar R, Pechirra P, Cristóvão P, Baltazar N. Mortalidade atribuível Ao vírus sincicial respiratório em Portugal entre 2014 e 2018. Instituto Nac De Saúde Doutor Ricardo Jorge Observações Bol Epidemiológico 2019, Número 25(Artigos breves nº2).
29.
go back to reference Nunes B, Viboud C, Machado A, Ringholz C, Rebelo-de-Andrade H, Nogueira P, Miller M. Excess mortality associated with Influenza epidemics in Portugal, 1980 to 2004. PLoS ONE. 2011;6(6):e20661.PubMedPubMedCentralCrossRef Nunes B, Viboud C, Machado A, Ringholz C, Rebelo-de-Andrade H, Nogueira P, Miller M. Excess mortality associated with Influenza epidemics in Portugal, 1980 to 2004. PLoS ONE. 2011;6(6):e20661.PubMedPubMedCentralCrossRef
30.
go back to reference Nielsen J, Vestergaard LS, Richter L, Schmid D, Bustos N, Asikainen T, Trebbien R, Denissov G, Innos K, Virtanen MJ, et al. European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of Influenza B be reconsidered? Clin Microbiol Infect. 2019;25(10):1266–76.PubMedCrossRef Nielsen J, Vestergaard LS, Richter L, Schmid D, Bustos N, Asikainen T, Trebbien R, Denissov G, Innos K, Virtanen MJ, et al. European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of Influenza B be reconsidered? Clin Microbiol Infect. 2019;25(10):1266–76.PubMedCrossRef
31.
go back to reference Kalligeros M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, van Aalst R, Chit A, Mylonakis E. Influenza vaccine effectiveness against influenza-associated hospitalization in children: a systematic review and meta-analysis. Vaccine. 2020;38(14):2893–903.PubMedCrossRef Kalligeros M, Shehadeh F, Mylona EK, Dapaah-Afriyie C, van Aalst R, Chit A, Mylonakis E. Influenza vaccine effectiveness against influenza-associated hospitalization in children: a systematic review and meta-analysis. Vaccine. 2020;38(14):2893–903.PubMedCrossRef
32.
go back to reference Worby CJ, Chaves SS, Wallinga J, Lipsitch M, Finelli L, Goldstein E. On the relative role of different age groups in Influenza epidemics. Epidemics. 2015;13:10–6.PubMedPubMedCentralCrossRef Worby CJ, Chaves SS, Wallinga J, Lipsitch M, Finelli L, Goldstein E. On the relative role of different age groups in Influenza epidemics. Epidemics. 2015;13:10–6.PubMedPubMedCentralCrossRef
33.
go back to reference Agency UHS. The national influenza immunisation programme 2022 to 2023: information for healthcare practitioners. In., vol. Published 20 September 2022; 2022. Agency UHS. The national influenza immunisation programme 2022 to 2023: information for healthcare practitioners. In., vol. Published 20 September 2022; 2022.
34.
go back to reference Czaja CA, Miller L, Colborn K, Cockburn MG, Alden N, Herlihy RK, Simões EAF. State-level estimates of excess hospitalizations and deaths associated with Influenza. Influenza Other Respir Viruses. 2020;14(2):111–21.PubMedCrossRef Czaja CA, Miller L, Colborn K, Cockburn MG, Alden N, Herlihy RK, Simões EAF. State-level estimates of excess hospitalizations and deaths associated with Influenza. Influenza Other Respir Viruses. 2020;14(2):111–21.PubMedCrossRef
35.
go back to reference Leung VKY, Wong JY, Barnes R, Kelso J, Milne GJ, Blyth CC, Cowling BJ, Moore HC, Sullivan SG. Excess respiratory mortality and hospitalizations associated with Influenza in Australia, 2007–2015. Int J Epidemiol. 2021;51(2):458–67.CrossRef Leung VKY, Wong JY, Barnes R, Kelso J, Milne GJ, Blyth CC, Cowling BJ, Moore HC, Sullivan SG. Excess respiratory mortality and hospitalizations associated with Influenza in Australia, 2007–2015. Int J Epidemiol. 2021;51(2):458–67.CrossRef
36.
go back to reference Nielsen J, Krause TG, Mølbak K. Influenza-associated mortality determined from all-cause mortality, Denmark 2010/11-2016/17: the FluMOMO model. Influenza Other Respir Viruses. 2018;12(5):591–604.PubMedPubMedCentralCrossRef Nielsen J, Krause TG, Mølbak K. Influenza-associated mortality determined from all-cause mortality, Denmark 2010/11-2016/17: the FluMOMO model. Influenza Other Respir Viruses. 2018;12(5):591–604.PubMedPubMedCentralCrossRef
37.
go back to reference Rodrigues A, Silva S, Torres R, Guiomar R, Pechirra P, Cristovão P, Nunes B. Respiratory syncytial virus attributable mortality in Portugal between 2014 and 2018. 2019. Rodrigues A, Silva S, Torres R, Guiomar R, Pechirra P, Cristovão P, Nunes B. Respiratory syncytial virus attributable mortality in Portugal between 2014 and 2018. 2019.
38.
go back to reference Organization WH. Global epidemiological surveillance standards for influenza. 2013. Organization WH. Global epidemiological surveillance standards for influenza. 2013.
39.
go back to reference Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI. The underrecognized burden of Influenza in young children. N Engl J Med. 2006;355(1):31–40.PubMedCrossRef Poehling KA, Edwards KM, Weinberg GA, Szilagyi P, Staat MA, Iwane MK, Bridges CB, Grijalva CG, Zhu Y, Bernstein DI. The underrecognized burden of Influenza in young children. N Engl J Med. 2006;355(1):31–40.PubMedCrossRef
Metadata
Title
Uncovering the burden of Influenza in children in Portugal, 2008–2018
Authors
Alberto Caldas Afonso
Catarina Gouveia
Gustavo Januário
Mafalda Carmo
Hugo Lopes
Hélène Bricout
Catarina Gomes
Filipe Froes
Publication date
01-12-2024
Publisher
BioMed Central
Keyword
Influenza
Published in
BMC Infectious Diseases / Issue 1/2024
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-023-08685-z

Other articles of this Issue 1/2024

BMC Infectious Diseases 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine